Annotations: 8XJ0

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
B		e8xj0B01	A: beta barrels	X: cradle loop barrel	H: RIFT-related	T: acid protease	F:	ECOD (v294.2)
D	WD40	e8xj0D1	A: beta barrels	X: cradle loop barrel	H: RIFT-related	T: acid protease	F: WD40	ECOD (v294.2)
F	WD40	e8xj0F1	A: beta barrels	X: cradle loop barrel	H: RIFT-related	T: acid protease	F: WD40	ECOD (v294.2)
H	WD40	e8xj0H1	A: beta barrels	X: cradle loop barrel	H: RIFT-related	T: acid protease	F: WD40	ECOD (v294.2)
A		e8xj0A01	A: beta barrels	X: cradle loop barrel	H: RIFT-related	T: acid protease	F:	ECOD (v294.2)
C	WD40	e8xj0C1	A: beta barrels	X: cradle loop barrel	H: RIFT-related	T: acid protease	F: WD40	ECOD (v294.2)
E	WD40	e8xj0E1	A: beta barrels	X: cradle loop barrel	H: RIFT-related	T: acid protease	F: WD40	ECOD (v294.2)
G	WD40	e8xj0G1	A: beta barrels	X: cradle loop barrel	H: RIFT-related	T: acid protease	F: WD40	ECOD (v294.2)

Chain	Chain Class	Chain Subclass	Chain Type	Antigen Name(s)	Provenance Source
B, D, F, H	Heavy Chain	IGHV3	-	-	SAbDab (2026-06-12)
A, C, E, G	Light Chain	IGKV1	Kappa	-	SAbDab (2026-06-12)

Chain	Name	Target	Provenance Source
B, D, F, H	Remtolumab	IL17A, TNF/TNFA	Therapeutic SAbDab (2026-06-12)
A, C, E, G	Adalimumab	TNF/TNFA, IL17A	Therapeutic SAbDab (2026-06-12)

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.

8XJ0 | pdb_00008xj0